SAM
PFE icon

Symphony Asset Management’s Pfizer PFE Stock Holding History

Symphony Asset Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-39,135
Closed -$1.25M – 368
2017
Q2 		$1.25M Sell
39,135
-1,664
-4% -$52.5K 0.14% 160
2017
Q1 		$1.32M Sell
40,799
-54,036
-57% -$1.7M 0.13% 171
2016
Q4 		$2.92M Sell
94,835
-30,971
-25% -$946K 0.3% 84
2016
Q3 		$4.04M Sell
125,806
-23,622
-16% -$790K 0.41% 55
2016
Q2 		$4.99M Buy
149,428
+26,351
+21% +$841K 0.54% 45
2016
Q1 		$3.46M Sell
123,077
-1,535
-1% -$43.8K 0.37% 69
2015
Q4 		$3.82M Sell
124,612
-52,746
-30% -$1.66M 0.42% 58
2015
Q3 		$5.29M Buy
177,358
+2,084
+1% +$66.8K 0.64% 33
2015
Q2 		$5.58M Sell
175,274
-15,194
-8% -$495K 0.7% 33
2015
Q1 		$6.29M Buy
190,468
+27,311
+17% +$868K 0.73% 32
2014
Q4 		$4.82M Buy
163,157
+63,477
+64% +$1.82M 0.6% 37
2014
Q3 		$2.8M Buy
99,680
+59,675
+149% +$1.67M 0.29% 75
2014
Q2 		$1.13M Buy
40,005
+12,544
+46% +$358K 0.12% 200
2014
Q1 		$837K Buy
27,461
+10,354
+61% +$309K 0.08% 222
2013
Q4 		$497K Sell
17,107
-14,122
-45% -$411K 0.04% 284
2013
Q3 		$851K Buy
31,229
+9,406
+43% +$256K 0.09% 214
2013
Q2 		$580K Buy
+21,823
New +$603K 0.06% 291

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Symphony Asset Management's PFE Position: Q3 2017 in Review

Symphony Asset Management sold out of Pfizer (PFE) in Q3 2017, closing a stake of 39,135 shares — an estimated $1.25M sold.

Symphony Asset Management first reported a position in PFE in Q2 2013 and held it in 17 quarters. The position peaked at $6.29M in Q1 2015. 2,042 funds tracked by Wall St. Rank hold PFE as of Q3 2017.

  • Symphony Asset Management reported no remaining Pfizer position as of Q3 2017 after selling out during the quarter.
  • Symphony Asset Management sold 39,135 Pfizer shares in Q3 2017, an estimated $1.25M.
  • Symphony Asset Management first reported a position in Pfizer in Q2 2013 and held it in 17 quarters.
  • Symphony Asset Management's Pfizer position peaked at $6.29M in Q1 2015.
  • 2,042 funds tracked by Wall St. Rank held Pfizer as of Q3 2017.

Based on Symphony Asset Management's 13F filing for Q3 2017, filed 13 Nov 2017.